Multifactorial pharmacological evaluation of incretin drugs in the treatment of type 2 diabetes: a structured approach to the rapyselection (liraglutide, semaglutide, tirzepatide
| dc.contributor.author | Shcherbyna, Yevheniia | |
| dc.date.accessioned | 2026-06-12T17:40:31Z | |
| dc.date.issued | 2026 | |
| dc.identifier.citation | Shcherbyna Ye. Multifactorial pharmacological evaluation of incretin drugs in the treatment of type 2 diabetes: a structured approach to the rapyselection (liraglutide, semaglutide, tirzepatide) / Ye. Shcherbyna // ISIC─2026 : International scientific interdisciplinary conference of young scientific and medical students, Kharkiv, 25–27 May, 2026 / KhNMU. – Kharkiv, 2026. – P. 414─415. | |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/38163 | |
| dc.language.iso | en | |
| dc.publisher | KNMU | |
| dc.subject | 2026а | |
| dc.title | Multifactorial pharmacological evaluation of incretin drugs in the treatment of type 2 diabetes: a structured approach to the rapyselection (liraglutide, semaglutide, tirzepatide | |
| dc.type | Theses |